Media ReleasesSomnomed Limited

View All Somnomed Limited News

SomnoMed, 2018 AGM Addresses - Chairman and CEO

Two important decisions have been made by your Board in the last ten days:

1. To reach agreement with our Company’s CEO, Mr Derek Smith, to step down and to appoint Mr Verdal-Austin as new CEO of SomnoMed Limited.

2. Today we decided to close all operations of our RSS subsidiary from 1st January 2019.

Both decisions need some further explanation.

Two and a half years ago we decided to proceed with the implementation of the S3 business model of a “Direct to Patient” concept for the treatment of OSA in treatment centre to be set up across the US by our US subsidiary Renew Sleep Solutions, Inc.

The decision was based on the successful three year history of S3, which had started operations in Texas during the financial year 2012/13. By 2016 S3 had become the biggest customer of SomnoMed North America and demonstrated the financial viability of its concept.

For further information please download PDF attached:
Download this document

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.